The efficacy of trazodone in reducing stress related behaviours in hospitalised dogs or dogs confined postsurgery

Published:

2023-05-26

Share
Open Access Logo

DOI

https://doi.org/10.18849/ve.v8i2.550

Abstract

PICO question

In hospitalised dogs or dogs confined postsurgery, does administration of trazodone reduce stress related behaviours compared to no treatment with trazodone?

 

Clinical bottom line

Category of research

Treatment.

Number and type of study designs reviewed

Three papers were critically reviewed. One was a prospective, randomised, blinded observational study, another was a randomised, placebo-controlled clinical trial, and the last was a non-randomised prospective, open-label clinical trial.

Strength of evidence

Weak.

Outcomes reported

The administration of trazodone to hospitalised dogs reduced several observed stress related behaviours compared to a control group that was environmentally matched to the treatment group (Gilbert-Gregory et al., 2016). In dogs subjected to postsurgical confinement at home, trazodone administration was not more effective at reducing stress related behaviours compared with a placebo in one study (Gruen et al., 2017); however, it was effective when observed in a non-placebo controlled clinical trial (Gruen et al., 2014). Further investigation with a larger sample size would assist in strengthening the evidence of an association between trazodone administration and a reduction in the behavioural signs of stress in dogs.

Conclusion

The available evidence weakly supports the hypothesis that administration of trazodone is an effective treatment in reducing stress related behaviours in hospitalised dogs and dogs confined post-surgery, and further studies are required to confirm its efficacy. The quality of the evidence when hospitalised dogs was studied was moderate (Gilbert-Gregory et al., 2016), however in dogs studied that were confined postsurgery, the evidence is weaker (Gruen et al., 2014; Gruen et al., 2017). Different trazodone doses were evaluated in the studies and so further studies focusing on dose effects are required to determine appropriate dose rates. Further studies also need to be conducted to evaluate the appropriate length of time that trazodone should be given prior to a stressful event, as well as whether trazodone needs to be used in conjunction with other anxiolytic drugs to optimise efficacy.

 

How to apply this evidence in practice

The application of evidence into practice should take into account multiple factors, not limited to: individual clinical expertise, patient’s circumstances and owners’ values, country, location or clinic where you work, the individual case in front of you, the availability of therapies and resources.

Knowledge Summaries are a resource to help reinforce or inform decision making. They do not override the responsibility or judgement of the practitioner to do what is best for the animal in their care.

References

Beerda, B., Schilder, M.B.H., van Hooff, J.A.R.A.M. & de Vries, H.W. (1997). Manifestations of chronic and acute stress in dogs. Applied Animal Behaviour Science. 52(3–4), 307–319. DOI: https://doi.org/10.1016/S0168-1591(96)01131-8

Beerda, B., Schilder, M.B.H., van Hooff, J.A.R.A.M., de Vries, H.W. & Mol, J.A. (1998). Behavioural, saliva cortisol and heart rate responses to different types of stimuli in dogs. Applied Animal Behaviour Science. 58(3–4), 365–381. DOI: https://doi.org/10.1016/S0168-1591(97)00145-7

Ciribassi, J.J. & Ballantyne, K. (2014). Using clonidine and trazodone for anxiety-based behavior disorders in dogs. Veterinary Medicine (1985). 109(4), 131.

Dhand, N.K. & Khatkar, M.S. (2014). Statulator: An online statistical calculator. Sample Size Calculator for Estimating a Single Proportion. [online]. Available from: http://statulator.com/SampleSize/ss1P.html [Accessed Sep 21].

Frank, D. (2014). Recognizing Behavioral Signs of Pain and Disease: A Guide for Practitioners. Veterinary Clinics of North America: Small Animal Practice. 44(3):507–524. DOI: https://doi.org/10.1016/j.cvsm.2014.01.002

Gaynor, J.S. & Muir, W. (2009). Chapter 5 Assessing Pain. Handbook of veterinary pain management, 2nd St. Louis: Mosby Elsevier, 67–92.

Gilbert-Gregory, S.E., Stull, J.W., Rice, M.R. & Herron ,M.E. (2016). Effects of trazodone on behavioral signs of stress in hospitalized dogs. Journal of the American Veterinary Medical Association. 249(11), 1281–1291. DOI: https://doi.org/10.2460/javma.249.11.1281

Grimm, K.A., Lamont, L.A., Tranquilli, W.J., Greene, S.A. & Robertson, S.A. (2015). Veterinary Anesthesia and Analgesia: The Fifth Edition of Lumb and Jones. Hoboken: Wiley. DOI: http://dx.doi.org/10.1002/9781119421375

Gruen,E. (2012). Trazodone: for behavior and beyond (oral presentation). American Veterinary Medical Association Annual Convention, San Diego, CA.

Gruen, M.E., Roe, S.C., Griffith, E., Hamilton, A. & Sherman, B.L. (2014). Use of trazodone to facilitate postsurgical confinement in dogs. Journal of the American Veterinary Medical Association. 245(3), 296–301. DOI: https://doi.org/10.2460/javma.245.3.296

Gruen, M.E. & Sherman, B.L. (2008). Use of trazodone as an adjunctive agent in the treatment of canine anxiety disorders: 56 cases (1995–2007). Journal of the American Veterinary Medical Association. 233(12), 1902–1907. DOI: https://doi.org/10.2460/javma.233.12.1902

Gruen, M.E., Roe, S.C., Griffith, E.H. & Sherman, B.L. (2017). The use of trazodone to facilitate calm behavior after elective orthopedic surgery in dogs: Results and lessons learned from a clinical trial. Journal of Veterinary Behavior. 22, 41–45. DOI: https://doi.org/10.1016/j.jveb.2017.09.008

Hadgu, A., Nordbø, A. & Skjeldestad, F.E. (2012). One in 16 Quadrillion: Importance of Blinding in Research Reproducibility. Epidemiology. 23(3), 503–504. [online]. Available from: https://www.jstor.org/stable/23214289 [Accessed Sep 21].

Hammond, F., Malec, J.F., Nick, T.G., & Buschbacher, R.M. (2014). Chapter 9 Sample Size and Power. Handbook for clinical research: design, statistics, and implementation, 1st ed. New York: Springer Publishing Company, Incorporated, 115–117.

Jay, A.R., Krotscheck, U., Parsley, E., Benson, L., Kravitz, A., Mulligan, A., Silva, J., Mohammed, H. & Schwark, W.S. (2013). Pharmacokinetics, bioavailability, and hemodynamic effects of trazodone after intravenous and oral administration of a single dose to dogs. American Journal of Veterinary Research. 74(11), 1450–1456. DOI: https://doi.org/10.2460/ajvr.74.11.1450

Lloyd, J.K.F. (2017). Minimising Stress for Patients in the Veterinary Hospital: Why It Is Important and What Can Be Done about It. Veterinary Sciences. 4(2), 22. DOI: https://doi.org/10.3390/vetsci4020022

Overall, K. (2013). Chapter 2 The Science and Theory Underlying Behavioural Medicine. Manual of Clinical Behavioral Medicine for Dogs and Cats. Saint Louis: Elsevier, 47.

Papich, M.G. (2016a). Gabapentin. In: M.G. Papich, ed. Saunders Handbook of Veterinary Drugs, 4th St. Louis: W.B. Saunders, 349–350. DOI: https://doi.org/10.1016/B978-0-323-24485-5.00016-4

Papich, M.G. (2016b). Fluoxetine Hydrochloride. In: M.G. Papich, ed., Saunders Handbook of Veterinary Drugs, 4th St. Louis: W.B. Saunders, 339–341. DOI: https://doi.org/10.1016/B978-0-323-24485-5.00272-2

Papich, M.G. (2016c). Acepromazine Maleate. In: M.G. Papich, ed. Saunders Handbook of Veterinary Drugs, 4th St. Louis: W.B. Saunders, 1–3. DOI: https://doi.org/10.1016/B978-0-323-24485-5.00010-3

Papich, M.G. (2016d). Trazodone Hydrochloride. In: M.G. Papich, ed. Saunders Handbook of Veterinary Drugs, 4th St. Louis: W.B. Saunders, 804–806. DOI: https://doi.org/10.1016/B978-0-323-24485-5.00566-0

Steimer, T. (2002). The biology of fear- and anxiety-related behaviors. Dialogues in Clinical Neuroscience. 4(3), 231–249. DOI: https://doi.org/10.31887/DCNS.2002.4.3/tsteimer

Vol. 8 No. 2 (2023): The second issue of 2023

Section: Knowledge Summaries

Categories :  Small Animal  /  Dogs  /  Cats  /  Rabbits  /  Production Animal  /  Cattle  /  Sheep  /  Pig  /  Equine  /  Exotics  /